Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity
Jing Wang, Dmitri Mouradov, Xiaojing Wang, Robert N Jorissen, Matthew C Chambers, Lisa J Zimmerman, Suhas Vasaikar, Christopher G Love, Shan Li, Kym Lowes, Karl-Johan Leuchowius, Helene Jousset, Janet Weinstock, Christopher Yau, John Mariadason, Zhiao Shi, Yuguan Ban, Xi Chen, Robert JC Coffey, Robbert JC Slebos Show all
Gastroenterology | W B SAUNDERS CO-ELSEVIER INC | Published : 2017
Awarded by NHMRC Project
Awarded by Cancer Council Victoria
Awarded by National Cancer Institute (NCI) CPTAC awards
Awarded by NCI SPORE award
Awarded by Leidos Biomedical Research, Inc.
Awarded by Victorian Life Sciences Computation Initiative (VLSCI)
Awarded by NATIONAL CANCER INSTITUTE
This study was supported by the Ludwig Institute for Cancer Research, a NHMRC Project Grant (APP1079362), a Cancer Council Victoria Grant-in-Aid (APP1060964) and the Victorian Government's Operational Infrastructure Support Program, by National Cancer Institute (NCI) CPTAC awards U24CA159988 and U24CA210954, by NCI SPORE award P50CA095103, and by contract 15X038 from Leidos Biomedical Research, Inc. The authors also thank the support from NCI-Funded Special Programs of Research Excellence in GI Cancer. This research was supported by a Victorian Life Sciences Computation Initiative (VLSCI) grant numbers VR0310 and VR0311 on its Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government, Australia. O.M.S. is a NHMRC R.D. Wright Biomedical Fellow (APP1062226). B.Z. is Cancer Prevention & Research Institutes of Texas (CPRIT RR160027) Scholar and McNair Medical Institute Scholar.